Reading Disorder
Conditions
Interventions
Trial Group:Clinical routine intervention combined with 12-week reading disorder rehabilitation software intervention
Control Group:Conventional clinical intervention guidance
Sponsors
Beijing Children's Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Age
7 Years to 12 Years
Inclusion criteria
Inclusion criteria: 1. Aged 7–12 years, regardless of gender; 2. Nonverbal Intelligence Quotient (IQ) greater than 80 on the Wechsler Intelligence Scale for Children-Fourth Edition (WISC-IV); 3. Word reading accuracy score (Standardized Chinese Character Recognition Test) falling more than 1.5 standard deviations below the grade-level mean, OR word reading accuracy score falling more than 1 standard deviation below the grade-level mean concurrently with a word reading fluency score (Standardized Word List Reading Test) falling more than 1.5 standard deviations below the grade-level mean; 4. Score on at least one subtest of the standardized cognitive assessment battery (Phonological Awareness Test, Morphological Production Test, Orthographic Judgment Test, Rapid Automatized Naming Test) falling more than 1 standard deviation below the grade-level mean; 5. Normal educational opportunities, without evidence of educational deprivation or inappropriate instruction; 6. Ability to comply with the researcher’s verbal or written instructions and to adhere to the requirements of all assessments and training sessions; 7. The patient and/or their legal guardian agree to participate in the study and voluntarily provide written informed consent.
Exclusion criteria
Exclusion criteria: 1. History of traumatic brain injury, brain tumor, or neurological disorders such as cerebral palsy or epilepsy; 2. Other psychiatric or psychotic disorders, such as anxiety disorder or depression; 3. Other severe neurodevelopmental disorders, such as autism; 4. Use of medications that may affect reading ability within the past 3 months: central nervous system stimulants (e.g., methylphenidate extended-release tablets); selective norepinephrine reuptake inhibitors (e.g., atomoxetine); alpha-adrenergic agonists (e.g., clonidine); antipsychotics (e.g., aripiprazole); 5. Visual or auditory functional abnormalities; 6. Participation in another clinical trial within the past 3 months without completion of follow-up; 7. Other cases deemed unsuitable for enrollment by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean difference in the change from baseline to post-12-week intervention in the Chinese Character Recognition Test score.; | — |
Secondary
| Measure | Time frame |
|---|---|
| Mean difference in word list reading score improvement from baseline after 12 weeks of intervention in participants;Software Usability Assessment; | — |
Countries
China
Contacts
Public ContactLiang Aimin
Beijing Children's Hospital, Capital Medical University
Outcome results
None listed